OrthoPediatrics Corp. KIDS
At closeNov 4, 2026, 4:01 PM EST
After hours · Nov 4, 4:01 PM ET
- YTD
- +88.68%
- 1 year
- +102.11%
- Market cap
- 874.96M
- Revenue (ttm)
- 189.67M
- Profit margin
- -15.00%
- EPS (ttm)
- -1.42
- Shares out
- 24.22M
- Forward P/E
- -21.54
- YTD return
- +88.68%
- 1-year return
- +102.11%
- Volume
- 555.34K
- Avg volume
- 284.60K
- Open
- 32.09
- Previous close
- 31.41
- Day's range
- 32.09 – 34.53
- 52-week range
- 14.42 – 34.53
- Beta
- 1.16
- Analysts
- Buy
- Price target
- 40.17 (+19.9%)
- Earnings date
- Aug 5, 2024
5D +5.97 (+23.64%)
Key statistics
- Enterprise value
- 545.13M
- PEG ratio
- 0.00
- Price / sales
- 2.89
- Price / book
- 1.48
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 36.50%
- Free cash flow
- -50.25M
- Total cash
- 76.06M
- Total debt
- 79.24M
- Return on equity
- -7.63%
- Short % of float
- 13.23%
- 50-day average
- 25.24
- 200-day average
- 28.68
Analyst view
Consensus: buy
- Target (low)
- 25.00
- Target (mean)
- 40.17
- Target (high)
- 50.00
- Strong buy3
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Aug 5, 2024
Expected Aug 5, 2024. Consensus EPS estimate -0.25667.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | -0.12 | -0.18 | -0.06 | -50.00% |
| Aug 5, 2024 | Jun 1, 2024 | -0.31 | -0.23 | +0.08 | +25.81% |
| Aug 5, 2024 | Jun 1, 2024 | -0.31 | — | — | — |
| May 6, 2024 | Mar 1, 2024 | -0.42 | -0.30 | +0.12 | +28.57% |
| May 6, 2024 | Mar 1, 2024 | -0.42 | — | — | — |
| Mar 6, 2024 | Dec 1, 2023 | -0.28 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 18, 2024 | Truist Securities | main | Hold | Hold |
| Nov 8, 2024 | Needham | reit | Buy | Buy |
| Oct 14, 2024 | Truist Securities | main | Hold | Hold |
| Sep 13, 2024 | Truist Securities | reit | Hold | Hold |
| Sep 13, 2024 | JMP Securities | reit | Market Outperform | Market Outperform |
| Sep 13, 2024 | Needham | reit | Buy | Buy |
About OrthoPediatrics Corp.
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- orthopediatrics.com
News
OrthoPediatrics to Participate in Upcoming Conferences 
All You Need to Know About OrthoPediatrics (KIDS) Rating Upgrade to Buy 
Lake Street Maintains Buy on OrthoPediatrics, Raises Price Target to $38 
Canaccord Genuity Maintains Buy on OrthoPediatrics, Raises Price Target to $30 - Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $28
12 Health Care Stocks Moving In Wednesday's Intraday Session 
TD Cowen Maintains Buy on OrthoPediatrics, Raises Price Target to $28 
Stifel Maintains Buy on OrthoPediatrics, Raises Price Target to $27 
Piper Sandler Reiterates Overweight on OrthoPediatrics, Raises Price Target to $30 
BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $30
Your note
Sign in to keep a note on KIDS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAILEY DAVID R | Chief Executive Officer | Stock Award(Grant) | Jun 10, 2024 | 229,779 |
| GERRITZEN DANIEL J. | General Counsel | Sale | Aug 20, 2024 | 77,304 |
| HAUSER JOSEPH W | Officer | Stock Award(Grant) | Jun 10, 2024 | 90,794 |
| HITE FRED L | Chief Operating Officer | Stock Award(Grant) | Jun 10, 2024 | 151,090 |
| HUGHES BRYAN W | Director | Stock Award(Grant) | May 27, 2024 | 12,826 |
| ODLE GREGORY A | Officer | Stock Award(Grant) | Jun 10, 2024 | 115,374 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Brown Capital Management, LLC | 9.26% | 2,241,920 | 50.71M | Sep 29, 2024 |
| Brown Advisory Inc. | 6.60% | 1,597,403 | 36.13M | Sep 29, 2024 |
| Blackrock Inc. | 5.31% | 1,286,903 | 29.11M | Sep 29, 2024 |
| Braidwell LP | 4.57% | 1,107,770 | 25.06M | Sep 29, 2024 |
| Granahan Investment Management LLC | 4.17% | 1,010,259 | 22.85M | Sep 29, 2024 |
| Vanguard Group Inc | 3.95% | 956,055 | 21.63M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Brown Capital Management Small Company Fund | 3.84% | 929,420 | 21.02M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 2.06% | 498,064 | 11.27M | Sep 29, 2024 |
| Brown Advisory Fds--Brown Advisory Small Cap Growth Fd | 1.93% | 467,008 | 10.56M | Oct 30, 2024 |
| iShares Russell 2000 ETF | 1.70% | 410,662 | 9.29M | Oct 30, 2024 |
| JNL Series Trust-JNL/Multi Manager Small Cap GrowthFd | 1.21% | 291,845 | 6.60M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.10% | 266,690 | 6.03M | Sep 29, 2024 |